POST Online Media Lite Edition


Anthera Pharmaceuticals announces personnel changes

Staff writer |
Hayward, Ca., USA - April 2, 2014, Hayward, Ca., USA - Anthera Pharmaceuticals, Inc., a biopharmaceutical company, announced the appointment of Steven Engle to the board and the departure of James Healy from its board of directors.

Mr. Engle has served as the Chief Executive Officer of Averigon Consulting, an advisory firm to the life sciences industry, since 2011. Prior to Averigon, he was the Chairman, Chief Executive Officer and President of Xoma Corporation, a public biotechnology company.

Prior to Xoma Corporation, Mr. Engle was Chairman and Chief Executive Officer of La Jolla Pharmaceutical Company.

Prior to La Jolla Pharmaceuticals Company, Mr. Engle served as the Vice President of Marketing for Cygnus, a drug delivery company, where he helped gain FDA approval of and launch Nicotrol for smoking cessation.

Mr. Engle is a member of the Board of Directors of BayBio and has served on the board of the Lupus Foundation of America. Mr. Engle holds a MSEE and BSEE, each from the University of Texas at Austin.


What to read next

Anthera announces departure of SVP, product development
Anthera names William Shanahan as chief medical officer
Anthera appoints Brian R. Mueller to board